Pelicci G, Pagliacci M C, Lanfrancone L, Pelicci P G, Grignani F, Nicoletti I
Istituto di Clinica Medica I, Università di Perugia, Italy.
J Endocrinol Invest. 1990 Sep;13(8):657-62. doi: 10.1007/BF03349589.
The effects of somatostatin-14 (SS-14) and the somatostatin-analog octreotide (SMS 201-995, Sandostatin) on proliferation of GH3 pituitary tumor cells were investigated in vitro. SMS 201-995 exerted a significant, but transient, inhibition on GH3 cell growth which reached a maximum at 24 h and was no longer detectable at 48 h. The concentration that evoked the strongest inhibitory effect was 10 nM SMS 201-995, while lower and higher doses resulted in a less pronounced effect. The inhibitory effect SMS 201-995 exerted on cell proliferation was associated with a dose- and time-related reduction in both c-myc and c-fos mRNA levels. SS-14 had no noteworthy influence on either cell proliferation or c-myc and c-fos protooncogene expression. These data demonstrate that SS-analogs transiently inhibit pituitary tumor cell proliferation in vitro.
研究了生长抑素 -14(SS -14)和生长抑素类似物奥曲肽(SMS 201 -995,善宁)对GH3垂体肿瘤细胞体外增殖的影响。SMS 201 -995对GH3细胞生长产生显著但短暂的抑制作用,在24小时达到最大值,48小时时不再可检测到。引起最强抑制作用的浓度为10 nM SMS 201 -995,而较低和较高剂量的作用则不那么明显。SMS 201 -995对细胞增殖的抑制作用与c -myc和c -fos mRNA水平的剂量和时间相关降低有关。SS -14对细胞增殖或c -myc和c -fos原癌基因表达均无显著影响。这些数据表明,生长抑素类似物在体外可短暂抑制垂体肿瘤细胞增殖。